Co-Authors
This is a "connection" page, showing publications co-authored by Sarah Buchan and Jonathan Gubbay.
Connection Strength
1.016
-
Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada. Viruses. 2021 Jan 18; 13(1).
Score: 0.231
-
Surveillance of persons-who tested negative for COVID-19 in Ontario, January 22-February 22, 2020. Can Commun Dis Rep. 2020 May 07; 46(5):150-154.
Score: 0.220
-
Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort. Vaccine. 2019 07 18; 37(31):4392-4400.
Score: 0.207
-
Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada. PLoS One. 2017; 12(11):e0187834.
Score: 0.186
-
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study. BMJ. 2021 08 20; 374:n1943.
Score: 0.060
-
S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021. JAMA. 2021 05 25; 325(20):2115-2116.
Score: 0.059
-
Influenza Vaccine Effectiveness Among Patients With Cancer: A Population-Based Study Using Health Administrative and Laboratory Testing Data From Ontario, Canada. J Clin Oncol. 2019 10 20; 37(30):2795-2804.
Score: 0.052